Archive - May 2020
Trailing Clovis, AstraZeneca gets FDA approval for Lynparza in prostate cancer
Biopharma body welcomes EU-UK free trade agreement docs
People with diabetes at higher risk of amid pandemic
Roche partners with Vividion on novel E3 Ligases
COVID-19 related delays to cancer treatment could cost thousands of lives, research shows
EU approves Novartis’ SMA gene therapy Zolgensma
Lynparza Approved in the US for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Nordstrom Starts Selling $4 Reusable Cloth Face Masks Amid Pandemic